New study: Depression patients still symptom-free 5 years after taking psychedelic mushrooms | Change in Action

New study: Depression patients still symptom-free 5 years after taking psychedelic mushrooms | Change in Action

Why this story matters: While it may not dominate the 24-hour news cycle, the development highlighted in this article represents a significant shift toward a better future, proving that constructive action is consistently gaining ground behind the scenes. Quick summary: This story highlights recent developments related to study, showing how constructive action can lead to meaningful results. Five years ago, a group of patients with clinical depression participated in a therapy trial for psilocybin, the psychedelic substance produced by over 200 species of mushrooms. The study, published by the Journal of the American Medical Association, involved two participant groups, with one receiving treatment immediately and the other receiving it after a short waiting period. Ultimately, both groups took two doses of psilocybin alongside 13 hours of psychotherapy. In 2025, the majority of participants did a follow-up study, and the results were overwhelmingly positive: Two-thirds of trial partici…